Skip to main content
OpenTrials
Completed

NCT Number: NCT03349021

Bougiecap for Treatment of Benign Stenosis in GI Tract

Feasibility testing of a cap-assisted endoscopic bougienage for benign upper GI stenosis with direct optical control.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universitätklinikum Ulm, Ulm, Baden-Wurttemberg, Germany

Loading trial locations.

About this study

Benign stenosis in the GI tract are endoscopically treated by using Savary-Gilliard Dilators. This method, although sufficient in its interventional success, provides only haptic control and often requires wire guidance or X-ray imaging for monitoring the position of the stenosis, the dilator and the dilation process.

To guarantee the missing optical feedback and enhance the intraprocedural control a conical, clear cap was developed. This single use device is attachable to the front end of an endoscope and provides direct visual evaluation of the mucosal damage and progress of the Bougienage, making x-ray imaging obsolete while resulting in an effective dilation. For the bougienage treatment, the endoscope with the cap on top is inserted into the patient's GI tract and aimed at the stenosis. By pushing the endoscope forward the cone shaped cap expands the mucosal diameter by conversion of longitudinal to radial force vectors. Lateral and frontal openings allow suction and flush during procedure.

The clear tapering cap is now to be tested for ist technical feasibility and ability to improve patients' quality of life following treatment. Therefore a quality of life questionnaire (Swal QoL) evaluating the patients' dysphagia is done right before and two weeks after the bougienage and an effective dilation is proved by being able to pass the stenosis with the endoscope after the treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • benign Stenosis of the esophagus
  • indication for endoscopic treamtent of stenosis

Exclusion criteria

  • no informed consent
  • malignancy based Stenosis
  • no indication for endoscopic treamtent

Treatment and study plan

BougieCap

Device

Treatment of esophagel Stenosis by Bougiecap

Primary outcomes

  1. Efficient bougienage with BougieCap

    Time frame: Day 0 (directly) after endoscopy

    To measure the effect of bougienage a passage with the endoscope should be possible.after Treatment with the BougieCap (5mm Endoscope, 10mm endoscope)

Secondary outcomes

  1. Qol dysphagia

    Time frame: Day 0 before endoscopy and Day14 after treatment

    Evaluation of life Quality by a 13 questions questionnaire. Clinical symptoms of dysphagia and General Quality of life are evaluated

Sponsors and collaborators

Lead sponsor

University of Ulm

Other

Registry information

Official study title

The Bougiecap; a New Method for Treatment of Benign Stenosis in GI Tract

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Nov 21, 2017
Registry last updated
Oct 17, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.